United Therapeutics Corporation
UTHRNASDAQHealthcare● Active
$544.69
$-5.18(-0.94%)
Market Cap$23.1B
P/E Ratio—
52W High$609.35
52W Low$272.12
United Therapeutics Corporation（UTHR）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · UTHR · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.33B | $1.20B | $0.98B | $0.73B | $0.48B |
| Depreciation & Amort. | $0.09B | $0.07B | $0.05B | $0.05B | $0.05B |
| Stock-Based Comp. | $0.15B | $0.14B | $0.04B | $0.11B | $0.14B |
| Change in Working Capital | ($0.11B) | ($0.06B) | ($0.10B) | ($0.14B) | ($0.17B) |
| Net Cash from Operations | $1.56B | $1.33B | $0.98B | $0.80B | $0.60B |
| Investing Activities | |||||
| Capital Expenditure | ($0.52B) | ($0.25B) | ($0.23B) | ($0.14B) | ($0.12B) |
| Purchases of Investments | ($3.46B) | ($1.65B) | ($2.51B) | ($1.71B) | ($1.90B) |
| Sales of Investments | $1.58B | $2.37B | $2.14B | $1.03B | $1.53B |
| Net Cash from Investing | ($0.55B) | $0.42B | ($0.72B) | ($0.81B) | ($0.49B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($1.00B) | ($1.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.30B) | ($0.40B) | ($0.10B) | $0.00B | $0.00B |
| Net Cash from Financing | ($1.15B) | ($1.25B) | ($0.01B) | $0.08B | $0.04B |
| Free Cash Flow | |||||
| Free Cash Flow | $1.04B | $1.08B | $0.75B | $0.66B | $0.48B |
| FCF Margin %(computed) | 32.70% | 37.55% | 32.12% | 34.28% | 28.32% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解United Therapeutics Corporation
关于United Therapeutics Corporation（UTHR）现金流量表
United Therapeutics Corporation 2025财年经营活动现金流$1.56B，自由现金流$1.04B（FCF利润率32.70%），资本支出($0.52B)。
常见问题
UTHR · 4 问United Therapeutics Corporation 2025财年自由现金流$1.04B，同比down3.7%。
UTHR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10